Dabur India Reports Q1 Consolidated Revenue of ₹37.64 Billion

NEW DELHI — Indian consumer goods giant Dabur India Limited (NSE: DABUR | BSE: 500096) announced its consolidated financial results for the June-ending quarter (Q1 FY27). The science-based Ayurveda and consumer goods company reported consolidated revenue from operations of ₹37.64 billion (INR 3,764 crore), closely aligning with Institutional Brokers' Estimate System (IBES) consensus forecasts of ₹37.65 billion.

During the same period, Dabur India achieved a consolidated net profit after tax of ₹5.91 billion (INR 591 crore). The performance highlights steady demand across the company's healthcare, home care, personal care, and food and beverage portfolios amidst evolving consumer spending patterns in urban and rural domestic markets.

Operational Highlights and Revenue Trajectory

Dabur India’s consolidated revenue of ₹37.64 billion was anchored by steady execution across its core domestic verticals and key international markets. The company’s financial performance matched street expectations, reflecting resilience across its main product categories despite variable weather conditions and localized inflationary pressures on raw material inputs.

The FMCG manufacturer maintained market share across primary product lines, including healthcare supplements, oral care, digestives, and hair care. Demand momentum in rural markets continued to show sequential recovery, narrowing the growth differential with urban distribution channels.

With consolidated net profit reaching ₹5.91 billion, Dabur's bottom-line performance was supported by supply chain optimization, disciplined ad-spend allocations, and manufacturing cost efficiencies across its regional production facilities.

Performance Across Key Business Segments

Dabur India operates eight distinct power brands across healthcare, personal care, and food verticals. Operational trends across key product lines during the quarter included:

• Healthcare Vertical: Steady consumer demand for flagship brands including Dabur Chyawanprash, Dabur Honey, PudinHara, and Honitus supported category margins.

• Personal Care & Oral Care: Oral care categories maintained steady volume momentum behind flagship lines such as Dabur Red Paste and Meswak, while hair care products saw sustained distribution reach.

• Foods & Beverages: The Réal brand portfolio maintained steady penetration across modern trade and e-commerce platforms.

• International Business: Dabur’s international operations contributed positively, driven by volume growth across key markets in the Middle East, Sub-Saharan Africa, and North America.

Market Implications and Investor Context

Dabur India’s Q1 financial performance closely matching the IBES consensus estimate of ₹37.65 billion provides clarity to equity analysts and institutional investors regarding near-term earnings predictability.

For retail consumers and trade distribution partners, Dabur’s stable revenue generation signals consistent product availability and ongoing expansion of the firm’s direct distribution footprint across tier-2, tier-3, and rural markets.

Market analysts note that FMCG volume growth across India remains tied to agricultural output, rural income trajectories, and commodity price stability. Dabur’s operational results reflect a balanced product mix capable of navigating broader macroeconomic shifts.

Official Regulatory Disclosures

According to official corporate filings submitted to Indian stock exchanges:

"The Board of Directors at its meeting reviewed and approved the un-audited consolidated financial results for the quarter ended June. The company recorded consolidated revenue from operations of ₹37,640 million and a consolidated net profit after tax of ₹5,910 million."

Quote Section

According to officials, the company's focus remains centered on expanding direct retail distribution, driving brand penetration across rural markets, and optimizing operational costs to preserve operating margins across all key operating verticals.

Why It Matters

Dabur India’s ability to meet market benchmarks with ₹37.64 billion in revenue and ₹5.91 billion in net profit reflects sustained consumer trust and operational efficiency. Matching IBES estimates reassures investors regarding earnings consistency in the Indian fast-moving consumer goods (FMCG) sector amidst changing consumption trends.

Key Facts at a Glance

• Consolidated Operational Revenue: ₹37.64 billion (INR 3,764 crore) for Q1.

• IBES Revenue Estimate: ₹37.65 billion (INR 3,765 crore).

• Consolidated Net Profit: ₹5.91 billion (INR 591 crore) for the quarter.

• Primary Ticker Symbols: NSE: DABUR | BSE: 500096.

• Core Verticals: Healthcare, Personal Care, Home Care, Foods & Beverages.

Frequently Asked Questions (FAQs)

What were Dabur India's Q1 revenue and net profit figures?

Dabur India reported consolidated revenue from operations of ₹37.64 billion and a consolidated net profit after tax of ₹5.91 billion for the June quarter.

Did Dabur India meet market expectations for Q1?

Yes, Dabur India's consolidated revenue of ₹37.64 billion was virtually aligned with the IBES consensus estimate of ₹37.65 billion.

What are Dabur India's main product categories?

Dabur India manufactures consumer products across Healthcare (Chyawanprash, Honey, Honitus), Personal Care (Amla Hair Oil, Red Paste), Home Care (Odomos, Sanifresh), and Foods & Beverages (Réal Fruit Power).

Where are Dabur India shares traded?

Shares of Dabur India Limited are listed and traded on the National Stock Exchange of India (NSE) under ticker DABUR and on the Bombay Stock Exchange (BSE) under scrip code 500096.

Source: Official regulatory announcements and earnings filings submitted to the National Stock Exchange of India (NSE), Bombay Stock Exchange (BSE), and Dabur India Limited Investor Relations.